Clinical Trials Directory

Trials / Completed

CompletedNCT05355662

Prognosis Analysis of Elderly Donor Liver in Liver Transplantation

Prognosis Analysis of Elderly Donor Liver From Donation After Cardiac Death in Liver Transplantation: a Multicenter Clinical Study

Status
Completed
Phase
Study type
Observational
Enrollment
11,569 (actual)
Sponsor
First Affiliated Hospital Xi'an Jiaotong University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Based on the follow-up data of elderly donation after cardiac death(DCD) donor liver transplant recipients from the CLTR, a database and official website for national data gathering. patients who met the enrollment criteria were screened for postoperative complications and survival for statistical analysis to understand the prognosis of patients and analyze the risk factors affecting their prognosis.

Detailed description

Since the Chinese organ donation system was developed in 2015, donation has been the only source of organs for transplantation in China. Adult patients (age 18 or older) who underwent LT using grafts from deceased donors between January 1st, 2015, and December 31st, 2018, were retrospectively identified using the CLTR, a database and official website for national data gathering. Based on the follow-up data of elderly DCD donor liver transplant recipients from the CLTR, a database and official website for national data gathering. patients who met the enrollment criteria were screened for postoperative complications and survival for statistical analysis to understand the prognosis of patients and analyze the risk factors affecting their prognosis.

Conditions

Interventions

TypeNameDescription
OTHERAgeThe study was retrospective and did not involve the application of interventions.

Timeline

Start date
2015-01-01
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2022-05-02
Last updated
2022-05-02

Source: ClinicalTrials.gov record NCT05355662. Inclusion in this directory is not an endorsement.